Sheffield BS - Search Results

1

Management of EGFR-mutated non-small-cell lung cancer: practical implications from a clinical and pathology perspective.

Cabanero M, Sangha R, Sheffield BS, Sukhai M, Pakkal M, Kamel-Reid S, Karsan A, Ionescu D, Juergens RA, Butts C, Tsao MS. Cabanero M, et al. Among authors: sheffield bs. Curr Oncol. 2017 Apr;24(2):111-119. doi: 10.3747/co.24.3524. Epub 2017 Apr 27. Curr Oncol. 2017. PMID: 28490925 Free PMC article. Review.

2

Relationship of thyroid transcription factor 1 to EGFR status in non-small-cell lung cancer.

Sheffield BS, Bosdet IE, Ali RH, Young SS, McNeil BK, Wong C, Dastur K, Karsan A, Ionescu DN. Sheffield BS, et al. Curr Oncol. 2014 Dec;21(6):305-8. doi: 10.3747/co.21.2148. Curr Oncol. 2014. PMID: 25489257 Free PMC article.

3

Investigation of PD-L1 Biomarker Testing Methods for PD-1 Axis Inhibition in Non-squamous Non-small Cell Lung Cancer.

Sheffield BS, Fulton R, Kalloger SE, Milne K, Geller G, Jones M, Jacquemont C, Zachara S, Zhao E, Pleasance E, Laskin J, Jones SJ, Marra MA, Yip S, Nelson BH, Gown AM, Ho C, Ionescu DN. Sheffield BS, et al. J Histochem Cytochem. 2016 Oct;64(10):587-600. doi: 10.1369/0022155416665338. Epub 2016 Sep 2. J Histochem Cytochem. 2016. PMID: 27591097 Free PMC article.

4

Loss of BRCA1-associated protein 1 (BAP1) expression is rare in non-small cell lung cancer.

Owen D, Sheffield BS, Ionescu D, Churg A. Owen D, et al. Among authors: sheffield bs. Hum Pathol. 2017 Feb;60:82-85. doi: 10.1016/j.humpath.2016.10.005. Epub 2016 Oct 28. Hum Pathol. 2017. PMID: 27984124

5

Personalized oncogenomics in the management of gastrointestinal carcinomas-early experiences from a pilot study.

Sheffield BS, Tessier-Cloutier B, Li-Chang H, Shen Y, Pleasance E, Kasaian K, Li Y, Jones SJ, Lim HJ, Renouf DJ, Huntsman DG, Yip S, Laskin J, Marra M, Schaeffer DF. Sheffield BS, et al. Curr Oncol. 2016 Dec;23(6):e571-e575. doi: 10.3747/co.23.3165. Epub 2016 Dec 21. Curr Oncol. 2016. PMID: 28050146 Free PMC article.

6

Consensus recommendations for optimizing biomarker testing to identify and treat advanced EGFR-mutated non-small-cell lung cancer.

Cheema PK, Gomes M, Banerji S, Joubert P, Leighl NB, Melosky B, Sheffield BS, Stockley T, Ionescu DN. Cheema PK, et al. Among authors: sheffield bs. Curr Oncol. 2020 Dec;27(6):321-329. doi: 10.3747/co.27.7297. Epub 2020 Dec 1. Curr Oncol. 2020. PMID: 33380864 Free PMC article.

7

Comprehensive genomic profiling for non-small-cell lung cancer: health and budget impact.

Johnston KM, Sheffield BS, Yip S, Lakzadeh P, Qian C, Nam J. Johnston KM, et al. Among authors: sheffield bs. Curr Oncol. 2020 Dec;27(6):e569-e577. doi: 10.3747/co.27.5995. Epub 2020 Dec 1. Curr Oncol. 2020. PMID: 33380872 Free PMC article.

8

[No title available]

[No authors listed] [No authors listed] PMID: 33704205

9

[No title available]

[No authors listed] [No authors listed] PMID: 33704213

10

Canadian Consensus Recommendations on the Management of MET-Altered NSCLC.

Cheema PK, Banerji SO, Blais N, Chu QS, Desmeules P, Juergens RA, Leighl NB, Sheffield BS, Wheatley-Price PF, Melosky BL. Cheema PK, et al. Among authors: sheffield bs. Curr Oncol. 2021 Nov 9;28(6):4552-4576. doi: 10.3390/curroncol28060386. Curr Oncol. 2021. PMID: 34898564 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page